ATE473636T1 - Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür - Google Patents

Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür

Info

Publication number
ATE473636T1
ATE473636T1 AT06735092T AT06735092T ATE473636T1 AT E473636 T1 ATE473636 T1 AT E473636T1 AT 06735092 T AT06735092 T AT 06735092T AT 06735092 T AT06735092 T AT 06735092T AT E473636 T1 ATE473636 T1 AT E473636T1
Authority
AT
Austria
Prior art keywords
glucan
foods containing
containing probiotic
isolated beta
food product
Prior art date
Application number
AT06735092T
Other languages
English (en)
Inventor
Barry R Goldin
Sherwood L Gorbach
Original Assignee
Barry R Goldin
Sherwood L Gorbach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barry R Goldin, Sherwood L Gorbach filed Critical Barry R Goldin
Application granted granted Critical
Publication of ATE473636T1 publication Critical patent/ATE473636T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/18—Milk in dried and compressed or semi-solid form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pediatric Medicine (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
AT06735092T 2005-02-15 2006-02-15 Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür ATE473636T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65293505P 2005-02-15 2005-02-15
PCT/US2006/005271 WO2006088923A2 (en) 2005-02-15 2006-02-15 A food containing a probiotic and an isolated beta-glucan and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE473636T1 true ATE473636T1 (de) 2010-07-15

Family

ID=36917003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06735092T ATE473636T1 (de) 2005-02-15 2006-02-15 Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür

Country Status (10)

Country Link
US (2) US7981412B2 (de)
EP (2) EP1858340B1 (de)
JP (1) JP4777365B2 (de)
KR (1) KR101355266B1 (de)
AT (1) ATE473636T1 (de)
AU (1) AU2006214382C1 (de)
DE (1) DE602006015438D1 (de)
DK (1) DK1858340T3 (de)
ES (1) ES2348403T3 (de)
WO (1) WO2006088923A2 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
WO2004112773A1 (en) * 2003-04-24 2004-12-29 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DE602006015438D1 (de) * 2005-02-15 2010-08-26 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
DE602006009144D1 (de) 2005-11-21 2009-10-22 Bioatlantis Ltd Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans
TW200808191A (en) 2006-08-09 2008-02-16 Genmont Biotech Inc Product containing Lactobacillus paracasei
AU2007302715B2 (en) * 2006-10-02 2013-01-31 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
DE102006046960A1 (de) * 2006-10-04 2008-04-10 Euro Allianz Pharma Gmbh Gesundheitsfördernde Nahrungsmittelzusammensetzung
CN101190239B (zh) * 2006-11-28 2010-11-03 景岳生物科技股份有限公司 含有类干酪乳杆菌的产品
EP2219655A2 (de) * 2007-11-13 2010-08-25 Biotec Pharmacon ASA Verfahren zur behandlung oder prävention von entzündlichen erkrankungen des darmtrakts
IL199781A0 (en) 2009-07-09 2010-05-17 Yohai Zorea Heat resistant probiotic compositions and healthy food comprising them
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
US8523837B2 (en) 2008-10-14 2013-09-03 Mead Johnson Nutrition Company Nutritive substance delivery container
US8801688B2 (en) 2008-10-14 2014-08-12 Mead Johnson Nutrition Company Nutritive substance delivery container
US7823723B2 (en) 2008-10-14 2010-11-02 Mead Johnson Nutrition Company Nutritive substance delivery container
US9474773B2 (en) * 2009-02-18 2016-10-25 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
TWI482642B (zh) * 2009-05-27 2015-05-01 用於減敏療法之免疫調節製劑組合物及其劑型結構
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
NZ600258A (en) * 2009-12-22 2014-01-31 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
EP2563372A4 (de) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Präbiotische formulierungen und verwendungsverfahren dafür
RU2541396C2 (ru) * 2010-05-28 2015-02-10 ЭмДжейЭн Ю.Эс. Холдингс ЛЛК Питательные композиции
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
DK2603240T3 (da) * 2010-08-09 2020-02-24 Degama Smart Ltd Probiotiske flydende fødevarer
ES2597038T3 (es) 2010-12-06 2017-01-13 Degama Berrier Ltd. Composición y método para mejorar la estabilidad y extender la vida útil de bacterias probióticas y productos alimenticios de las mismas
MY165488A (en) * 2010-12-08 2018-03-23 Nestec Sa Baby food products comprising hydrolyzed whole grain
US20120171231A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in stimulating immune cells
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
EP2604123A1 (de) 2011-12-15 2013-06-19 Friesland Brands B.V. Verfahren und Ernährungszusammensetzung zur Behandlung von Durchfall
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
WO2014136982A1 (ja) * 2013-03-08 2014-09-12 学校法人東京理科大学 乳酸菌増殖促進剤、制御性ｔ細胞増加剤、乳酸菌増殖促進方法、制御性ｔ細胞を増加させる方法、制御性ｔ細胞増加効果の評価方法、および乳酸菌増殖促進効果の評価方法
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US10543175B1 (en) 2013-05-17 2020-01-28 Degama Berrier Ltd. Film composition and methods for producing the same
AU2014313030B2 (en) 2013-08-26 2017-01-19 Meiji Co., Ltd. Antibody titer-increasing agent using lactic acid bacterium
JP6628802B2 (ja) * 2014-12-29 2020-01-15 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 食品組成物および使用方法
KR101660764B1 (ko) * 2015-02-06 2016-10-05 인지전기공업 주식회사 베타글루칸 이유식 제조방법 및 이에 의해 제조된 베타글루칸 이유식
US10588926B2 (en) * 2015-06-29 2020-03-17 Ferring B.V. Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
KR101805863B1 (ko) * 2015-07-01 2017-12-07 주식회사 위드바이오코스팜 신바이오틱 발효 산물의 제조 방법 및 이에 의하여 제조된 신바이오틱 발효산물
NL2016115B1 (en) 2016-01-18 2017-07-25 Innoso B V Food composition with fermented starch.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
US10576113B2 (en) 2016-04-19 2020-03-03 Akay Flavours & Aromatics Pvt, Ltd. Method of preparing stable, water soluble probiotic compositions based on millets and similar cereals
KR101684289B1 (ko) * 2016-05-17 2016-12-09 한국식품연구원 락토바실러스 sp. KCCM 11826P 균주를 이용한 고인산혈증 예방, 만성 신장질환 치료용 약학조성물 및 건강기능성 식품
US11197902B2 (en) * 2016-06-24 2021-12-14 Ig Biosciences Corporation Prebiotic neutraceutical compositions and methods of treatment using the same
CN107836707B (zh) * 2017-10-19 2020-09-08 广东省农业科学院蚕业与农产品加工研究所 一种具有改善糖脂代谢紊乱的健康食品基料的制备方法及应用
FI128699B (en) * 2017-12-22 2020-10-30 Valio Ltd Plant-based food product and process
CN109757731A (zh) * 2019-03-14 2019-05-17 广州普维君健药业有限公司 缓解乳糖不耐的益生菌组合物及其制备方法和应用
KR102257769B1 (ko) * 2019-06-07 2021-05-28 (주)큐젠바이오텍 베타글루칸을 포함하는 장내 균총 개선용 조성물 및 이의 용도
KR102161552B1 (ko) * 2019-06-07 2020-10-05 (주)큐젠바이오텍 베타글루칸을 포함하는 장내 균총 개선용 조성물 및 이의 용도
KR102257768B1 (ko) * 2019-06-07 2021-05-28 (주)큐젠바이오텍 베타글루칸을 포함하는 장내 균총 개선용 조성물 및 이의 용도
CN111000246A (zh) * 2019-12-27 2020-04-14 汤臣倍健股份有限公司 一种辅助降甘油三酯的益生菌膳食纤维组合物及其应用、保健品
IT202100032279A1 (it) * 2021-12-22 2023-06-22 St Gentili S R L Vitexina o suo isomero per uso nel trattamento di ASD
WO2025262017A1 (en) * 2024-06-18 2025-12-26 Société des Produits Nestlé S.A. Nutritional composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4874618A (en) 1985-12-27 1989-10-17 General Mills, Inc. Package containing a moisture resistant edible internal barrier
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
US20020150658A1 (en) 2001-04-16 2002-10-17 Clint Morrissette Food package containing food products in separate compartments separated by a burst seal and method of making
EP1429620A1 (de) * 2001-08-31 2004-06-23 Nutricopia, Inc. Gefrorene ernährungssüssspeisen und verfahren zu ihrer herstellung
US6835558B2 (en) 2002-02-04 2004-12-28 General Mills, Inc. Beta-glucan compositions and process therefore
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
JP3889647B2 (ja) * 2002-03-27 2007-03-07 株式会社Ａｄｅｋａ ヨーグルト類
KR100649855B1 (ko) * 2003-03-07 2006-11-28 가부시키가이샤 아우레오 β-글루칸 함유 조성물 및 상기 조성물을 이용한 변비개선제, 면역 부활제 및 피부용 보습제
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
DE602006015438D1 (de) * 2005-02-15 2010-08-26 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür

Also Published As

Publication number Publication date
AU2006214382B2 (en) 2011-06-02
US20080193485A1 (en) 2008-08-14
WO2006088923A3 (en) 2007-05-10
EP1858340A4 (de) 2008-09-17
JP2008529535A (ja) 2008-08-07
WO2006088923A2 (en) 2006-08-24
DK1858340T3 (da) 2010-09-27
AU2006214382A1 (en) 2006-08-24
EP2248430A2 (de) 2010-11-10
AU2006214382C1 (en) 2012-03-08
EP2248430A3 (de) 2011-01-12
US7981412B2 (en) 2011-07-19
KR20070121641A (ko) 2007-12-27
JP4777365B2 (ja) 2011-09-21
US20110274722A1 (en) 2011-11-10
US8404228B2 (en) 2013-03-26
EP1858340A2 (de) 2007-11-28
EP1858340B1 (de) 2010-07-14
DE602006015438D1 (de) 2010-08-26
KR101355266B1 (ko) 2014-02-06
ES2348403T3 (es) 2010-12-03

Similar Documents

Publication Publication Date Title
ATE473636T1 (de) Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
BE2021C505I2 (de)
ATE402617T1 (de) Prebiotische zubereitung
ZA200609378B (en) Molecularly imprinted polymers selective for nitrosamines and methods of using the same
ATE494275T1 (de) Herstellung von cis-pellitorin und verwendung als aromastoff
TW200738270A (en) Method of treating depression using a TNFα antibody
IL213523A0 (en) Compositions comprising blood group antigens
NO20072524L (no) Flavonoid sukker addisjonsprodukter, fremgangsmate for fremstilling og anvendelse derav
IT1391448B1 (it) "contenitore per prodotti fluidi, particolarmente farmaceutici, cosmetici, alimentari o simili
MX347179B (es) Metodo para mejorar el sabor.
WO2007068750A3 (en) Immunoglobulins directed against nogo
BRPI0917737A2 (pt) "método de produzir uma fração de umami ativa, fração ativa de umami, método de adicionar ou melhorar o sabor umami de um produto alimentar e método para preparar um produto alimentar"
ITMO20040351A1 (it) ''confezione per prodotti framaceutici,medicinali o simili,particolarmente fitofarmaci o fitosanitari''.
MY140063A (en) Sensoric imprinting
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
WO2006133014A3 (en) Acid-thickened food compositions and products
MX2007011264A (es) Composiciones nutricionales para modular la biodisponibilidad de vitamina c.
WO2005071067A3 (en) Non-animal origin stabilizers and processes for producing the same
DE60222895D1 (de) Linderung von fehlern in der augenkontrollfunktion
EA200870187A1 (ru) Пищевой продукт с гасителем вкуса и способ его изготовления
WO2009104184A3 (en) Extracts of sclerocarya birrea
DE602007007784D1 (de) Präbiotikumhaltiges flüssiges nahrungsmittelprodukt
ITMO20040229A1 (it) Metodi per processare i prodotti alimentari.
UA91781C2 (ru) Композиция полифенола и пептида и ее применение для улучшения состояния желудка
ITPR20040091A1 (it) Apparato e procedimento per trattare prodotti alimentari.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties